Guggenheim Capital LLC Teva Pharmaceutical Industries LTD Transaction History

Guggenheim Capital LLC

  • $13.9 Billion
  • Q2 2024

A detailed history of Guggenheim Capital LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Guggenheim Capital LLC holds 77,658 shares of TEVA stock, worth $1.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
77,658
Previous 33,243 133.61%
Holding current value
$1.39 Million
Previous $469,000 168.87%
% of portfolio
0.01%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$12.78 - $17.4 $567,623 - $772,820
44,415 Added 133.61%
77,658 $1.26 Million
Q1 2024

May 14, 2024
BUY
$10.67 - $14.43 $81,412 - $110,100
7,630 Added 29.79%
33,243 $469,000
Q4 2023

Feb 14, 2024
SELL
$8.12 - $10.63 $31,919 - $41,786
-3,931 Reduced 13.31%
25,613 $267,000
Q3 2023

Nov 14, 2023
SELL
$7.48 - $10.7 $90,126 - $128,924
-12,049 Reduced 28.97%
29,544 $301,000
Q2 2023

Aug 11, 2023
SELL
$7.2 - $9.47 $26,964 - $35,465
-3,745 Reduced 8.26%
41,593 $313,000
Q1 2023

May 10, 2023
BUY
$8.36 - $11.37 $379,025 - $515,493
45,338 New
45,338 $401,000
Q4 2021

Feb 14, 2022
SELL
$7.9 - $10.19 $343,357 - $442,887
-43,463 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$8.38 - $10.18 $103,208 - $125,376
12,316 Added 39.54%
43,463 $424,000
Q2 2021

Aug 13, 2021
BUY
$9.9 - $11.56 $52,737 - $61,580
5,327 Added 20.63%
31,147 $309,000
Q1 2021

May 13, 2021
SELL
$10.34 - $12.81 $95,903 - $118,812
-9,275 Reduced 26.43%
25,820 $298,000
Q4 2020

Feb 16, 2021
BUY
$8.61 - $11.04 $302,167 - $387,448
35,095 New
35,095 $338,000
Q4 2019

Feb 14, 2020
SELL
$6.53 - $10.72 $314,778 - $516,757
-48,205 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$6.16 - $9.6 $89,320 - $139,200
-14,500 Reduced 23.12%
48,205 $332,000
Q2 2019

Aug 14, 2019
BUY
$8.12 - $15.72 $94,459 - $182,870
11,633 Added 22.78%
62,705 $579,000
Q1 2019

May 15, 2019
SELL
$15.58 - $20.01 $37,392 - $48,024
-2,400 Reduced 4.49%
51,072 $801,000
Q4 2018

Feb 14, 2019
BUY
$14.59 - $23.84 $3,953 - $6,460
271 Added 0.51%
53,472 $824,000
Q3 2018

Nov 14, 2018
BUY
$21.06 - $25.65 $169,806 - $206,815
8,063 Added 17.86%
53,201 $1.15 Million
Q2 2018

Aug 14, 2018
SELL
$16.77 - $24.71 $193,475 - $285,079
-11,537 Reduced 20.36%
45,138 $1.1 Million
Q1 2018

May 15, 2018
SELL
$16.68 - $22.07 $180,043 - $238,223
-10,794 Reduced 16.0%
56,675 $969,000
Q4 2017

Feb 14, 2018
SELL
$11.23 - $19.1 $84,382 - $143,517
-7,514 Reduced 10.02%
67,469 $1.28 Million
Q3 2017

Nov 14, 2017
BUY
$15.41 - $32.17 $1.16 Million - $2.41 Million
74,983
74,983 $1.32 Million

Others Institutions Holding TEVA

# of Institutions
603
Shares Held
567M
Call Options Held
25.2M
Put Options Held
5.08M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email